Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11873283 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

Patent 11873283 was granted and assigned to Celgene on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Celgene

Current Assignee

Celgene

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118732830

Patent Inventor Names

Virginia Heather Sharron Grant0

Massimo Ammirante0

Stephen Norris0

Shuichan Xu0

Veronique Plantevin-Krenitsky0

Christopher Mayne0

Mark A. Nagy0

Joshua Hansen0

...

Date of Patent

January 16, 2024

Patent Application Number

174037420

Date Filed

August 16, 2021

Patent Citations

‌

US Patent 11149007 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11873283 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API